Changes in serum HER-2/neu levels of > 20% from baseline is associated with favorable clinical outcomes to Trastuzumab-based therapy Meeting Abstract
| Authors: | Price, C.; Ali, S.; Harris, L.; Brault, D.; Kostler, W.; Luftner, D.; Fornier, M.; Leitzel, K.; Lotz, J. P.; Pichon, M.; Lipton, A.; Thiel, R. P.; Esteva, F.; Tse, C.; Carney, W. P. |
| Abstract Title: | Changes in serum HER-2/neu levels of > 20% from baseline is associated with favorable clinical outcomes to Trastuzumab-based therapy |
| Meeting Title: | AACC 2007 Annual Meeting |
| Journal Title: | Clinical Chemistry |
| Volume: | 53 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2007 Jul 15-19 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0009-9147 |
| Publisher: | American Association for Clinical Chemistry |
| Date Published: | 2007-06-01 |
| Start Page: | A115 |
| Language: | English |
| ACCESSION: | WOS:000246843000363 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: C-37 - Poster Session - 59th Annual Meeting of the American-Association-for-Clinical-Chemistry - JUL 15-19, 2007 - San Diego, CA - S - "Source: Wos" |
MSK Authors
-
158Fornier